Jonathan J. Darrow

Harvard Medical School

Faculty

25 Shattuck St

Boston, MA 02115

United States

SCHOLARLY PAPERS

24

DOWNLOADS
Rank 4,952

SSRN RANKINGS

Top 4,952

in Total Papers Downloads

8,641

SSRN CITATIONS
Rank 36,084

SSRN RANKINGS

Top 36,084

in Total Papers Citations

5

CROSSREF CITATIONS

12

Scholarly Papers (24)

1.

Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs

Journal of Law, Medicine and Ethics, 2013, Vol. 14, No. 3: 590-610
Number of pages: 11 Posted: 20 Jun 2013 Last Revised: 12 Sep 2014
Donald W. Light, Joel Lexchin and Jonathan J. Darrow
Rowan University School of Osteopathic Medicine, York University and Harvard Medical School
Downloads 6,584 (973)

Abstract:

Loading...

2.

Social Networking Web Sites and the Dmca: A Safe-Harbor from Copyright Infringement Liability or the Perfect Storm?

NORTHWESTERN JOURNAL OF TECHNOLOGY & INTELLECTUAL PROPERTY, Vol. 6, No. 1, 2007
Number of pages: 36 Posted: 28 Oct 2010
Jonathan J. Darrow and Gerald Ferrera
Harvard Medical School and affiliation not provided to SSRN
Downloads 356 (86,779)

Abstract:

Loading...

DMCA, copyright, YouTube, Social Networking, digital

3.

Debunking the Evergreening Patents Myth

131(6) Harvard Law Record 6 (2010)
Number of pages: 3 Posted: 04 May 2012
Jonathan J. Darrow
Harvard Medical School
Downloads 329 (94,853)
Citation 1

Abstract:

Loading...

patents, drug, pharmaceutical, evergreen

4.

The Patentability of Enantiomers: Implications for the Pharmaceutical Industry

Stanford Technology Law Review, Vol. 2, 2007
Number of pages: 19 Posted: 29 Oct 2010
Jonathan J. Darrow
Harvard Medical School
Downloads 209 (152,184)

Abstract:

Loading...

patent, enantiomer, chiral, pharmaceutical, drug, isomer, obvious to try, obviousness

5.

Who Owns a Decedent’s E-Mails: Inheritable Probate Assets or Property of the Network?

NYU JOURNAL OF LEGISLATION & PUBLIC POLICY, Vol. 10, p. 281, 2007
Number of pages: 40 Posted: 28 Oct 2010
Jonathan J. Darrow and Gerald Ferrera
Harvard Medical School and affiliation not provided to SSRN
Downloads 176 (177,291)
Citation 1

Abstract:

Loading...

e-mail, copyright, inherit, probate, service provider, bailment

6.

The Search Engine Advertising Market: Lucrative Space or Trademark Liability?

Texas Intellectual Property Law Journal, Vol. 17, p. 223, Fall 2008
Number of pages: 45 Posted: 09 Nov 2010
Jonathan J. Darrow and Gerald Ferrera
Harvard Medical School and affiliation not provided to SSRN
Downloads 159 (193,541)

Abstract:

Loading...

7.

Essential Medicines: Why International Price Discrimination May Increasingly Be the Wrong Solution to a Global Drug Problem

Journal of Law, Medicine and Ethics, Vol. 39, p. 291, 2011
Number of pages: 11 Posted: 02 May 2012
Jonathan J. Darrow
Harvard Medical School
Downloads 133 (223,967)

Abstract:

Loading...

Essential Medicines, Global Health, Price Discrimination, Differential Pricing, WHO, advance market commitments, Internet Arbitrage, pharmaceutical tourism, drug patents

8.

Crowdsourcing Clinical Trials

Minnesota Law Review, Vol. 98, 805, 2014
Number of pages: 63 Posted: 28 Jan 2014
Jonathan J. Darrow
Harvard Medical School
Downloads 102 (271,648)

Abstract:

Loading...

Crowdsourcing, clinical trials, ethics, FDA, REMS, MedWatch, Sentinal, pharmaceuticals

9.

An Exploration of Compulsory Licensing as an Effective Policy Tool for Antiretroviral Drugs in India

Health Matrix: Journal of Law-Medicine, Vol. 23, No. 2, 2013
Number of pages: 34 Posted: 28 Jan 2014
Dipika Jain and Jonathan J. Darrow
OP Jindal Global University - Jindal Global Law School (JGLS) and Harvard Medical School
Downloads 98 (279,039)

Abstract:

Loading...

Patent, Pharmaceutical, Essential Medicines, Compulsory Licensing, TRIPS, Intellectual Property

10.

Adverse Employment Consequences Triggered by Criminal Convictions: Recent Cases Interpret State Statutes Prohibiting Discrimination

Wake Forest Law Review, Vol. 42, 2007
Number of pages: 48 Posted: 02 May 2012
Jonathan J. Darrow and Christine O'Brien
Harvard Medical School and affiliation not provided to SSRN
Downloads 95 (284,701)

Abstract:

Loading...

11.

Pharmaceutical Efficacy: The Illusory Legal Standard

Washington and Lee Law Review, Vol. 70, No. 4, 2013
Number of pages: 65 Posted: 28 Jan 2014
Jonathan J. Darrow
Harvard Medical School
Downloads 73 (334,038)

Abstract:

Loading...

pharmaceuticals, efficacy, safe and effective, FDA, FDCA, substantial evidence, gold standard, statistical significance

12.

The Neglected Dimension of Patent Law's PHOSITA Standard

Harvard Journal of Law and Technology, Vol. 23, No. 1, 2009
Number of pages: 32 Posted: 03 May 2012
Jonathan J. Darrow
Harvard Medical School
Downloads 61 (367,334)

Abstract:

Loading...

Patent, PHOSITA, "ordinary mechanic", KSR, invention

13.

Secondary Considerations: A Structured Framework for Patent Analysis

Albany Law Review, Vol. 74, p. 47, 2012
Number of pages: 46 Posted: 04 May 2012 Last Revised: 31 Oct 2012
Jonathan J. Darrow
Harvard Medical School
Downloads 51 (399,516)

Abstract:

Loading...

secondary considerations, secondary factors, objective indicia, obviousness, nonobviousness, patent, unexpected results, teaching away, Graham factors

14.

Employment Termination for Employee Blogging: Number One Tech Trend for 2005 and Beyond, or a Recipe for Getting Dooced?

UCLA Journal of Law and Technology, 2006
Number of pages: 49 Posted: 03 May 2012
Stephen Lichtenstein and Jonathan J. Darrow
Bentley University - Department of Law and Harvard Medical School
Downloads 49 (406,407)

Abstract:

Loading...

15.

'Do You Really Need My Social Security Number?' Data Collection Practices in the Digital Age

North Carolina Journal of Law and Technology, Vol. 10, No. 1, 2008
Number of pages: 58 Posted: 30 Oct 2010
Jonathan J. Darrow and Stephen Lichtenstein
Harvard Medical School and Bentley University - Department of Law
Downloads 49 (406,407)

Abstract:

Loading...

16.

Beating the Bluebook Blues: A Response to Judge Posner

Michigan Law Review First Impressions, Vol. 109, No. 92
Number of pages: 7 Posted: 04 May 2012
Stephen Darrow and Jonathan J. Darrow
Harvard University and Harvard Medical School
Downloads 45 (421,012)

Abstract:

Loading...

Bluebook, Posner, subciting, citation, legal citation

17.

When Markets Fail: Patents and Infectious Disease Products

73(3) Food & Drug L J 361 (2018)
Number of pages: 26 Posted: 22 Aug 2019
Jonathan J. Darrow, Michael S. Sinha and Aaron S. Kesselheim
Harvard Medical School, Harvard-MIT Center for Regulatory Science, Harvard Medical School and Brigham and Women's Hospital/Harvard Medical School
Downloads 28 (495,559)
Citation 1

Abstract:

Loading...

18.

The Question Remains after Raytheon Co. v. Hernandez: Whether No Rehire Rules Disparately Impact Alcoholics and Former Drug Abusers

U. Penn. J. Labor & Emp. L., 2004
Number of pages: 17 Posted: 03 May 2012
Christine Neylon O'Brien and Jonathan J. Darrow
Boston College - Carroll School of Management and Harvard Medical School
Downloads 21 (535,610)

Abstract:

Loading...

19.

At $28,000 a Dose, How Effective Is Acthar?

Bill of Health (Harvard), 2013
Number of pages: 4 Posted: 14 Nov 2019
Jonathan J. Darrow
Harvard Medical School
Downloads 6 (631,919)

Abstract:

Loading...

20.

Designing Development Programs for Non-Traditional Antibacterial Agents

Nature Communications (2019) 10:3416 DOI: 10.1038/s41467-019-11303-9, Boston Univ. School of Law, Public Law Research Paper No. #19-17 (2019)
Number of pages: 11 Posted: 24 Sep 2019
F2G Limited, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Harvard Law School, Harvard Medical School and Boston University School of Law
Downloads 5 (638,830)
Citation 1

Abstract:

Loading...

antibacterial resistance, antibacterial agents

21.

A New Approach to Treat Childhood Leukemia: Novartis’ CAR-T Therapy

45 JOURNAL OF LAW MEDICINE & ETHICS 692 (2018)
Number of pages: 12 Posted: 23 Aug 2019
Frazer Tessema and Jonathan J. Darrow
Harvard University - Brigham and Women's Hospital and Harvard Medical School
Downloads 5 (638,830)

Abstract:

Loading...

CAR-T, gene therapy, cancer, efficacy, FDA, drug

22.

Federal Circuit Review of USPTO Inter Partes Review Decisions, by the Numbers: How the AIA Has Impacted the Caseload of the Federal Circuit

98 J. Pat. & Trademark Off. Soc’y 105 (2016)
Number of pages: 15 Posted: 13 Nov 2019
Evan J. Wallach and Jonathan J. Darrow
affiliation not provided to SSRN and Harvard Medical School
Downloads 4 (645,964)
Citation 1

Abstract:

Loading...

IPR, inter partes review, USPTO, patent, AIA

23.

A New Wave of Vaccines for Non-Communicable Diseases: What Are the Regulatory Challenges?

70(2) Food Drug Law J. 243 (2015)
Number of pages: 17 Posted: 13 Nov 2019
Jonathan J. Darrow
Harvard Medical School
Downloads 3 (653,833)

Abstract:

Loading...

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol. 37, No. 1, 03.01.2019, p. 21-22.
Posted: 24 Apr 2019
Timo Minssen, Aaron S. Kesselheim and Jonathan J. Darrow
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol.37, No. 1, pp. 21-22 (2019); DOI: 10.1038/nbt.4324
Posted: 27 Jun 2019
Timo Minssen, Aaron S. Kesselheim and Jonathan J. Darrow
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

Other Papers (2)

Total Downloads: 20
1.

The High Cost of Health Care: Why Some Pay $240 for a $9 Bottle of Pills

Bill of Health Blog, February 2013
Number of pages: 4 Posted: 13 Nov 2013
Jonathan J. Darrow
Harvard Medical School
Downloads 11

Abstract:

Loading...

health care, cost, prescription, drugs, finasteride, Wal-Mart, generics, alopecia, Proscar

2.

Xolair for Chronic Itch: Magic Bullet or Marketing Hype?

Bill of Health Blog, February 2013
Number of pages: 3 Posted: 13 Nov 2013
Jonathan J. Darrow
Harvard Medical School
Downloads 9

Abstract:

Loading...

Xolair, omalizumab, hives, FDA, NEJM, placebo, ethics